Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation
Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunoco...
Gespeichert in:
Veröffentlicht in: | Hepatology (Baltimore, Md.) Md.), 1999-12, Vol.30 (6), p.1513-1520 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1520 |
---|---|
container_issue | 6 |
container_start_page | 1513 |
container_title | Hepatology (Baltimore, Md.) |
container_volume | 30 |
creator | Pessoa, Mario G. Bzowej, Natalie Berenguer, Marina Phung, Yume Kim, Michael Ferrell, Linda Hassoba, Howayda Wright, Teresa L. |
description | Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations. |
doi_str_mv | 10.1002/hep.510300610 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69302953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69302953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</originalsourceid><addsrcrecordid>eNp90DFv2zAQBWCiaNE4aceuAYeim9Ijj7SsMTCcJkCAdmhngaKOMAtZUniSg_z70LCRZMrE4T483j0hvim4UgD655bGK6sAAZYKPoiFsrosEC18FAvQJRSVwupMnDP_B4DK6NVncabAlmhRL8S82Q_dPMWhl0OQOcxNcYos13If08zyYXYceSQfiWXs5WFO_cTyMU5bybSnRNJvh454yiP_JsKFiZLsYiZySq7nsXP9AQ39F_EpuI7p6-m9EP9uNn_Xt8X971936-v7whs0UJgSTekbCJpaZSw43ZTtaqWhcdau2qbxBtolOm19GxrlPeqAtqGAS4NYebwQP465Yxoe5rxivYvsqcuL0DBzvawQdGUxw-IIfRqYE4V6THHn0lOtoD70XOe76pees788Bc_Njto3-lhsBt9PwLF3Xcj3-8ivTlVgwWRWHtlj7Ojp_U_r282f1w2eAdpbmJo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69302953</pqid></control><display><type>article</type><title>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Pessoa, Mario G. ; Bzowej, Natalie ; Berenguer, Marina ; Phung, Yume ; Kim, Michael ; Ferrell, Linda ; Hassoba, Howayda ; Wright, Teresa L.</creator><creatorcontrib>Pessoa, Mario G. ; Bzowej, Natalie ; Berenguer, Marina ; Phung, Yume ; Kim, Michael ; Ferrell, Linda ; Hassoba, Howayda ; Wright, Teresa L.</creatorcontrib><description>Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.510300610</identifier><identifier>PMID: 10573532</identifier><identifier>CODEN: HPTLD9</identifier><language>eng</language><publisher>Philadelphia, PA: W.B. Saunders</publisher><subject>Biological and medical sciences ; Cholestasis, Intrahepatic - pathology ; Cholestasis, Intrahepatic - virology ; Disease Progression ; DNA Mutational Analysis ; Evolution, Molecular ; Genetic Variation - genetics ; Hepacivirus - genetics ; Hepacivirus - immunology ; Hepacivirus - physiology ; Hepatitis C - pathology ; Hepatitis C - therapy ; Hepatitis C - virology ; Human viral diseases ; Humans ; Immunosuppression - adverse effects ; Infectious diseases ; Liver - pathology ; Liver - virology ; Liver Transplantation - adverse effects ; Medical sciences ; Phylogeny ; Recurrence ; Time Factors ; Viral diseases ; Viral diseases of the digestive system</subject><ispartof>Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1513-1520</ispartof><rights>Copyright © 1999 American Association for the Study of Liver Diseases</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</citedby><cites>FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.510300610$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.510300610$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1190504$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10573532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pessoa, Mario G.</creatorcontrib><creatorcontrib>Bzowej, Natalie</creatorcontrib><creatorcontrib>Berenguer, Marina</creatorcontrib><creatorcontrib>Phung, Yume</creatorcontrib><creatorcontrib>Kim, Michael</creatorcontrib><creatorcontrib>Ferrell, Linda</creatorcontrib><creatorcontrib>Hassoba, Howayda</creatorcontrib><creatorcontrib>Wright, Teresa L.</creatorcontrib><title>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.</description><subject>Biological and medical sciences</subject><subject>Cholestasis, Intrahepatic - pathology</subject><subject>Cholestasis, Intrahepatic - virology</subject><subject>Disease Progression</subject><subject>DNA Mutational Analysis</subject><subject>Evolution, Molecular</subject><subject>Genetic Variation - genetics</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - immunology</subject><subject>Hepacivirus - physiology</subject><subject>Hepatitis C - pathology</subject><subject>Hepatitis C - therapy</subject><subject>Hepatitis C - virology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunosuppression - adverse effects</subject><subject>Infectious diseases</subject><subject>Liver - pathology</subject><subject>Liver - virology</subject><subject>Liver Transplantation - adverse effects</subject><subject>Medical sciences</subject><subject>Phylogeny</subject><subject>Recurrence</subject><subject>Time Factors</subject><subject>Viral diseases</subject><subject>Viral diseases of the digestive system</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90DFv2zAQBWCiaNE4aceuAYeim9Ijj7SsMTCcJkCAdmhngaKOMAtZUniSg_z70LCRZMrE4T483j0hvim4UgD655bGK6sAAZYKPoiFsrosEC18FAvQJRSVwupMnDP_B4DK6NVncabAlmhRL8S82Q_dPMWhl0OQOcxNcYos13If08zyYXYceSQfiWXs5WFO_cTyMU5bybSnRNJvh454yiP_JsKFiZLsYiZySq7nsXP9AQ39F_EpuI7p6-m9EP9uNn_Xt8X971936-v7whs0UJgSTekbCJpaZSw43ZTtaqWhcdau2qbxBtolOm19GxrlPeqAtqGAS4NYebwQP465Yxoe5rxivYvsqcuL0DBzvawQdGUxw-IIfRqYE4V6THHn0lOtoD70XOe76pees788Bc_Njto3-lhsBt9PwLF3Xcj3-8ivTlVgwWRWHtlj7Ojp_U_r282f1w2eAdpbmJo</recordid><startdate>199912</startdate><enddate>199912</enddate><creator>Pessoa, Mario G.</creator><creator>Bzowej, Natalie</creator><creator>Berenguer, Marina</creator><creator>Phung, Yume</creator><creator>Kim, Michael</creator><creator>Ferrell, Linda</creator><creator>Hassoba, Howayda</creator><creator>Wright, Teresa L.</creator><general>W.B. Saunders</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199912</creationdate><title>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</title><author>Pessoa, Mario G. ; Bzowej, Natalie ; Berenguer, Marina ; Phung, Yume ; Kim, Michael ; Ferrell, Linda ; Hassoba, Howayda ; Wright, Teresa L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Cholestasis, Intrahepatic - pathology</topic><topic>Cholestasis, Intrahepatic - virology</topic><topic>Disease Progression</topic><topic>DNA Mutational Analysis</topic><topic>Evolution, Molecular</topic><topic>Genetic Variation - genetics</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - immunology</topic><topic>Hepacivirus - physiology</topic><topic>Hepatitis C - pathology</topic><topic>Hepatitis C - therapy</topic><topic>Hepatitis C - virology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunosuppression - adverse effects</topic><topic>Infectious diseases</topic><topic>Liver - pathology</topic><topic>Liver - virology</topic><topic>Liver Transplantation - adverse effects</topic><topic>Medical sciences</topic><topic>Phylogeny</topic><topic>Recurrence</topic><topic>Time Factors</topic><topic>Viral diseases</topic><topic>Viral diseases of the digestive system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pessoa, Mario G.</creatorcontrib><creatorcontrib>Bzowej, Natalie</creatorcontrib><creatorcontrib>Berenguer, Marina</creatorcontrib><creatorcontrib>Phung, Yume</creatorcontrib><creatorcontrib>Kim, Michael</creatorcontrib><creatorcontrib>Ferrell, Linda</creatorcontrib><creatorcontrib>Hassoba, Howayda</creatorcontrib><creatorcontrib>Wright, Teresa L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pessoa, Mario G.</au><au>Bzowej, Natalie</au><au>Berenguer, Marina</au><au>Phung, Yume</au><au>Kim, Michael</au><au>Ferrell, Linda</au><au>Hassoba, Howayda</au><au>Wright, Teresa L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>1999-12</date><risdate>1999</risdate><volume>30</volume><issue>6</issue><spage>1513</spage><epage>1520</epage><pages>1513-1520</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><coden>HPTLD9</coden><abstract>Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.</abstract><cop>Philadelphia, PA</cop><pub>W.B. Saunders</pub><pmid>10573532</pmid><doi>10.1002/hep.510300610</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-9139 |
ispartof | Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1513-1520 |
issn | 0270-9139 1527-3350 |
language | eng |
recordid | cdi_proquest_miscellaneous_69302953 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Biological and medical sciences Cholestasis, Intrahepatic - pathology Cholestasis, Intrahepatic - virology Disease Progression DNA Mutational Analysis Evolution, Molecular Genetic Variation - genetics Hepacivirus - genetics Hepacivirus - immunology Hepacivirus - physiology Hepatitis C - pathology Hepatitis C - therapy Hepatitis C - virology Human viral diseases Humans Immunosuppression - adverse effects Infectious diseases Liver - pathology Liver - virology Liver Transplantation - adverse effects Medical sciences Phylogeny Recurrence Time Factors Viral diseases Viral diseases of the digestive system |
title | Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A26%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20hepatitis%20C%20virus%20quasispecies%20in%20patients%20with%20severe%20cholestatic%20hepatitis%20after%20liver%20transplantation&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Pessoa,%20Mario%20G.&rft.date=1999-12&rft.volume=30&rft.issue=6&rft.spage=1513&rft.epage=1520&rft.pages=1513-1520&rft.issn=0270-9139&rft.eissn=1527-3350&rft.coden=HPTLD9&rft_id=info:doi/10.1002/hep.510300610&rft_dat=%3Cproquest_cross%3E69302953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69302953&rft_id=info:pmid/10573532&rfr_iscdi=true |